1Muhling OM, Wang Y, Panse P, et al. Transmyocardial laser revascularization preserves regional myocardial perfusion., an MRI first pass perfusion study. Cardiovasc Res, 2003,57 (1) :63-70.
2Lutter G, Martin J, von Samson P, et al. Microperfusion enhancement after TMLR in chronically ischemic porcine hearts.Cardiovasc Surg, 2001,9(3) : 281-291.
3Lutter G. Martin J, Dern P,et al. Evaluation of the indirect revascularization method after 3 months chronic myocardial ischemia. Eur J Cardiothorac Surg, 2000,18(1):38-45.
4Sayeed Shah U, Mann M J, Martin J, et al. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization. J Thorac Cardiovasc Surg, 1998,116(5) : 763-769.
5Sayeed-Shah U,Mann MJ,Martin J,et al.Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization[J].J Thorac Cardiovasc Surg,1998,116:763-769.
6Lutter G,Martin J,Von Samson P,et al.Microperfusion enhancement after TMLR in chronically ischemic porcine hearts[J].Cardiovasc Surg,2001,9:281-291.
7Lutter G,Martin J,Dern P,et al.Evaluation of the indirect revascularization method after 3 months chronic myocardial ischemia[J].Eur J Cardiothorac Surg,2000,18:38-45.
8Symes JF, Losordo DW, Vale PR, et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease[J]. Ann Thorac Surg, 1999, 68:830～837.
9Rosengart TK, Lee LY, Patel SR, et al. Angiogenesis gene therapy: phase Ⅰ assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease[J]. Circulation, 1999, 100:468～474.
10Sayeed-Shah U, Mann MJ, Martin J, et al. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization[J]. J Thorac Cardiovasc Surg, 1998, 116:763～769.
